Cargando…

Editorial: How pharmacogenomics, epigenetics, and data analysis could improve anticancer treatment?

Detalles Bibliográficos
Autores principales:	Jaafari, Abdeslam, Srinivasan, Subramani, Tilaoui, Mounir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686424/ https://www.ncbi.nlm.nih.gov/pubmed/36438848 http://dx.doi.org/10.3389/fphar.2022.1067022

Ejemplares similares

Differential Effect of Artemisinin Against Cancer Cell Lines
por: Tilaoui, Mounir, et al.
Publicado: (2014)

Comparative Phytochemical Analysis of Essential Oils from Different Biological Parts of Artemisia herba alba and Their Cytotoxic Effect on Cancer Cells
por: Tilaoui, Mounir, et al.
Publicado: (2015)

Editorial: NSAIDs Pharmacogenomics
por: Agúndez, José A. G., et al.
Publicado: (2021)

Editorial: Pharmacogenomics in neglected populations
por: Botton, Mariana R., et al.
Publicado: (2022)

Editorial: Big Data, Pharmacogenomics and Real-World Research in Pharmacology
por: Wei, James Cheng-Chung, et al.
Publicado: (2020)

Update and New Insights on Future Cancer Drug Candidates From Plant-Based Alkaloids
por: Tilaoui, Mounir, et al.
Publicado: (2021)

Editorial: Insights in Pharmacogenetics and Pharmacogenomics: 2021
por: Agúndez, José A. G., et al.
Publicado: (2022)

Editorial: Improving cancer chemotherapy through pharmacogenomics: a research topic
por: Quiñones, Luis A., et al.
Publicado: (2015)

Studies on the Dual Cytotoxicity and Antioxidant Properties of Berberis vulgaris Extracts and Its Main Constituent Berberine
por: El khalki, Lamyae, et al.
Publicado: (2018)

Editorial: Pharmacogenomics and ethnicity: Prevalence and clinical significance of pharmacogenomic biomarkers in indigenous and other populations
por: Patrinos, George P., et al.
Publicado: (2023)

Editorial: The utilization of bench-to-bedside approaches in pharmacogenomics
por: Rytkin, Eric, et al.
Publicado: (2023)

Editorial: The Potential of Machine Learning in Pharmacogenetics, Pharmacogenomics and Pharmacoepidemiology
por: Garcia-Agundez, Augusto, et al.
Publicado: (2022)

Editorial: Brief research reports in pharmacogenetics and pharmacogenomics: 2022
por: Sessa, Francesco, et al.
Publicado: (2023)

Editorial: Editor’s feature: negative findings in pharmacogenetics and pharmacogenomics
por: Agúndez, José A. G., et al.
Publicado: (2023)

Chemical Composition and Cytotoxic and Antibacterial Activities of the Essential Oil of Aloysia citriodora Palau Grown in Morocco
por: Oukerrou, Moulay Ali, et al.
Publicado: (2017)

Clinical practice guidelines for translating pharmacogenomic knowledge to bedside. Focus on anticancer drugs
por: Agúndez, José A. G., et al.
Publicado: (2014)

Editorial: Emerging talents in frontiers in pharmacology: pharmacogenetics and pharmacogenomics 2022
por: Klomp, Sylvia D., et al.
Publicado: (2023)

Editorial: From Trial and Error to Individualised Pharmacogenomics-Based Pharmacotherapy in Psychiatry
por: van Westrhenen, R., et al.
Publicado: (2021)

Editorial: The Potential of Machine-learning in Pharmacogenetics, Pharmacogenomics and Pharmacoepidemiology: Volume II
por: Garcia-Agundez, Augusto, et al.
Publicado: (2023)

Cannabidiol in sports: insights on how CBD could improve performance and recovery
por: Rojas-Valverde, Daniel, et al.
Publicado: (2023)

Pharmacogenomics: What is Next?
por: di Iulio, Julia, et al.
Publicado: (2012)

Pharmacogenomics in oncology care
por: Filipski, Kelly K., et al.
Publicado: (2014)

Editorial: Novel biomarkers for anticancer therapy
por: Wang, Ting, et al.
Publicado: (2023)

Editorial: Translation and implementation of pharmacogenomic testing in daily clinical practice: Considering current challenges and future needs
por: Miltyk, Wojciech, et al.
Publicado: (2022)

Whole genome sequencing in pharmacogenomics
por: Katsila, Theodora, et al.
Publicado: (2015)

Pharmacogenomics of Prostaglandin and Leukotriene Receptors
por: Cornejo-García, José A., et al.
Publicado: (2016)

Ethnic Diversity and Warfarin Pharmacogenomics
por: Asiimwe, Innocent G., et al.
Publicado: (2022)

Pharmacogenomics in clinical trials: an overview
por: Nogueiras-Álvarez, Rita
Publicado: (2023)

Editorial: Environmental Enrichment as a Treatment? Epigenetic Mechanisms, Challenges and Limitations
por: Redolat, Rosa, et al.
Publicado: (2021)

Pharmacogenomics of human P450 oxidoreductase
por: Pandey, Amit V., et al.
Publicado: (2014)

Pharmacogenomics and adverse drug reactions in children
por: Rieder, Michael J., et al.
Publicado: (2014)

Current clinical evidence on pioglitazone pharmacogenomics
por: Kawaguchi-Suzuki, Marina, et al.
Publicado: (2013)

Pharmacogenomics at the post-pandemic: If not now, then when?
por: Al-Mahayri, Zeina N.
Publicado: (2022)

The pharmacogenomic landscape of an Indigenous Australian population
por: Samarasinghe, Sumudu Rangika, et al.
Publicado: (2023)

Editorial: Pharmacogenetics and Pharmacogenomics in Latin America: Ethnic Variability, New Insights in Advances and Perspectives: A RELIVAF-CYTED Initiative
por: Esperón, Patricia, et al.
Publicado: (2022)

Pharmacogenomics Implementation Training Improves Self-Efficacy and Competency to Drive Adoption in Clinical Practice
por: Adesta, Fadhli, et al.
Publicado: (2021)

Evolution of pharmacogenomic services and implementation of a multi-state pharmacogenomics clinic across a large rural healthcare system
por: Van Heukelom, Joel, et al.
Publicado: (2023)

Editorial: Natural Product Epigenetic Modulators and Inhibitors
por: Ntie-Kang, Fidele, et al.
Publicado: (2021)

Editorial: Epigenetic regulation and therapy resistance in cancer
por: Zhu, Yongxia, et al.
Publicado: (2023)

Individualized medication based on pharmacogenomics and treatment progress in children with IgAV nephritis
por: Yang, Xuerong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l1vq4a3c3k3etdlrf0loa1nljj